In the 10 years since Gilead debuted a revolutionary treatment for hepatitis C, a wave of new therapies have been used to cure millions of people around the world of the blood-borne virus. Today, 15 countries, including Egypt, Canada and Australia, are on track to eliminate the virus during this decade. The arsenal of drugs has generated tens of billions of dollars for pharmaceutical companies.